It’s still early days for artificial intelligence (AI) in the pharma and healthcare space. So much depends on navigating the regulatory environment, yet great strides are being made … they’re just not quite as sexy as, say, a chatbot or what IBM once promised Watson would be.

To learn more about what Intouch’s Justin Chase, EVP of innovation, and other pharma marketers see as the behind-the-scenes benefits of AI, check out this special feature from PharmaLive.